Our goal is to eliminate the financial barriers to psychedelic therapy.
We do this by providing supplemental funds to those in need.
“My prediction is [that in 10 years] there will be 5,000-6,000 [psychedelic centers] in the United States.”
RICK DOBLIN - founder of MAPS
We believe in the healing power of psychedelic medicines. And, we believe that everyone who is ready and deemed appropriate for psychedelic therapy deserves access.
Ketamine treatment is currently legal and underway in clinics across the United States.
Rick Doblin and MAPS are doing the work to make MDMA and psilocybin treatments legal. And they are beginning to set up the infrastructure to train the therapists needed to facilitate treatment.
Yet, this treatment is expensive – MDMA and psilocybin treatment will cost between $10,000-$14,000 per person – and insurance will not be paying for it. Ketamine treatment varies widely in costs between $3,000-$20,000 per person, depending on cost per session and number of sessions.
This is where we come in.
We will support clients at these psychedelic centers with the funds to make their treatment affordable.
Specifically, we take donations to grant access for treatments with Ketamine, MDMA, and Psilocybin.
We dedicate our financial and human capital to both for-profit and not-for-profit initiatives that support evolution of consciousness.
We aspire to be one of the catalyzers of a movement that will positively and materially impact the lives of billions of people in the span of one generation.